Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has 390 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 1,093,757 | 5.41% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | -742,749 | -4.63% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 10,350,000 | 94.95% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | 760,578 | 13.20% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | -1,169,404 | -43.80% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -305,016 | -48.66% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 6,466 | 0.10% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 737,713 | 253.49% | $0.00 |
| World Investment Advisors | 31 Dec, 2025 | 0 | 8,197 | 59.50% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 133,921 | 4.28% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 69,104 | 7.53% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 224 | 25.17% | $0.00 |
| Slate Path Capital LP | 31 Dec, 2025 | 0 | -2,458,500 | -49.35% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 900,000 | 0.00% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 504,883 | 30.22% | $0.00 |
| Western Financial Corp/CA | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 0 | 6,264 | 0.30% | $0.00 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 470,000 | 0.00% | $0.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,526,164 | 497.39% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | -599,974 | -59.99% | $0.00 |